Citation Impact
Citing Papers
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
2007 Standout
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Molecular Pathogenesis of Cholestasis
1998
Cancer Prevention With Natural Compounds
2010
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Molecular Characterization of a Broad Selectivity Neutral Solute Channel
1998
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Kinetic Analysis of the Mechanism and Specificity of Protein-disulfide Isomerase Using Fluorescence-quenched Peptides
1998 StandoutNobel
Aquaporin water channels: molecular mechanisms for human diseases1
2003 StandoutNobel
Shared Principles in NF-κB Signaling
2008 Standout
BILE ACID TRANSPORT
1999
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
2006
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
Tumor-suppressive Maspin Regulates Cell Response to Oxidative Stress by Direct Interaction with Glutathione S-Transferase
2005
Mammalian lipoxygenases and their biological relevance
2014
Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family
2003
Drug-Induced Hepatotoxicity
2003 Standout
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
The Clinical Utility of Biomarkers in the Management of Pancreatic Adenocarcinoma
2014
Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
2007 Nature
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Structural determinants of water permeation through aquaporin-1
2000 StandoutNatureNobel
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
Differential inhibition by cyclosporins of primary‐active ATP‐dependent transporters in the hepatocyte canalicular membrane
1993
Epigenetics in Cancer
2008 Standout
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI
2019 StandoutNobel
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
2000 Standout
Network organization of the human autophagy system
2010 StandoutNature
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Regulation of genistein-induced differentiation in human acute myeloid leukaemia cells (HL60, NB4)
2008
2004 WHO Classification of the Renal Tumors of the Adults
2006
Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin
2011 StandoutNobel
Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome
1996
Emerging roles of purinergic signaling in gastrointestinal epithelial secretion and hepatobiliary function
1999
Immunity, Inflammation, and Cancer
2010 Standout
Multi-targeted therapy of cancer by genistein
2008 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
An overview of renal cell cancer: Pathology and genetics
2012
Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma
2011
Eicosanoids and cancer
2010 Standout
Targeting tumor–stromal interactions in bone metastasis
2013
Aquaporin water channels – from atomic structure to clinical medicine
2002 StandoutNobel
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Cloning of a human nucleoside transporter implicated in the Cellular uptake of adenosine and chemotherapeutic drugs
1997
Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer
2010
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation
1998 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Nucleoside transporters: molecular biology and implications for therapeutic development
1999
Cancer-related inflammation
2008 StandoutNature
Renal cell carcinoma
2017 Standout
cDNA Cloning of the Hepatocyte Canalicular Isoform of the Multidrug Resistance Protein, cMrp, Reveals a Novel Conjugate Export Pump Deficient in Hyperbilirubinemic Mutant Rats
1996
Cardioprotection in female rats subjected to chronic volume overload: synergistic interaction of estrogen and phytoestrogens
2007
Tumor-Stromal Interactions in Bone Metastasis
2010
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
New Roles for β-Arrestins in Cell Signaling: Not Just for Seven-Transmembrane Receptors
2006 StandoutNobel
Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors
2006
Adeno-Associated Virus 2-Mediated Intratumoral Prostate Cancer Gene Therapy: Long-Term Maspin Expression Efficiently Suppresses Tumor Growth
2005
A genetic screen in zebrafish identifies the mutantsvps18, nf2andfoie grasas models of liver disease
2005
Tumor Suppressor Maspin Is Up-Regulated during Keratinocyte Senescence, Exerting a Paracrine Antiangiogenic Activity
2004
Gene Expression Profiling Revealed Survivin as a Target of 3,3′-Diindolylmethane-Induced Cell Growth Inhibition and Apoptosis in Breast Cancer Cells
2006
Autocrine signaling through ATP release represents a novel mechanism for cell volume regulation.
1996
Anti-cancer-prostaglandin-induced cell-cycle arrest and its modulation by an inhibitor of the ATP-dependent glutathione S-conjugate export pump (GS-X pump)
1998 StandoutNobel
18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.
2006
Molecular Physiology of P2X Receptors
2002 Standout
Bis- and Trisindolylmethanes (BIMs and TIMs)
2009 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation
2002
Integration of transplanted hepatocytes into host liver plates demonstrated with dipeptidyl peptidase IV-deficient rats.
1995
Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9
2002 StandoutNobel
Matrix Metalloproteinase-Assisted Triggered Release of Liposomal Contents
2007
Role of β-arrestin 1 in the metastatic progression of colorectal cancer
2006
Four faces of cellular senescence
2011 Standout
Review
1997
The GS-X Pump in Plant, Yeast, and Animal Cells: Structure, Function, and Gene Expression
1997
Aquaglyceroporin AQP9: Solute permeation and metabolic control of expression in liver
2003 StandoutNobel
Cellular and Molecular Biology of the Aquaporin Water Channels
1999 StandoutNobel
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Molecular Pathogenesis of Cholestasis
2004
Aquaporins in the Kidney: From Molecules to Medicine
2002 StandoutNobel
Works of Mingxin Che being referenced
A Proposal for a New and More Practical Grading Scheme for Pancreatic Ductal Adenocarcinoma
2005
Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model
2007
Regulation of Gene Expression and Inhibition of Experimental Prostate Cancer Bone Metastasis by Dietary Genistein
2004
Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model
2007
Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15‐lipoxygenase‐2 in prostate cancer
2008
Erythrocyte Membrane Transport of Glutathione Conjugates and Oxidized Glutathione in the Dubin–Johnson Syndrome and in Rats With Hereditary Hyperbilirubinemia
1992
Differential Expression of Thromboxane Synthase in Prostate Carcinoma
2004
Prostate Cancer Treatment is Enhanced by GenisteinIn VitroandIn Vivoin a Syngeneic Orthotopic Tumor Model
2006
Primary Structure and Functional Expression of a cDNA Encoding the Bile Canalicular, Purine-specific Na+-Nucleoside Cotransporter
1995
Clear Cell Renal Cell Carcinoma
2005
Matrix Metalloproteinase Activity and Osteoclasts in Experimental Prostate Cancer Bone Metastasis Tissue
2005
Thromboxane A2 Receptors in Prostate Carcinoma: Expression and Its Role in Regulating Cell Motility via Small GTPase Rho
2008
Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis
2003
The biology of the bile canaliculus, 1993
1993
Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model
2004
Ectonucleotidases, purine nucleoside transporter, and function of the bile canalicular plasma membrane of the hepatocyte
1997